Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke

Completed

Phase N/A Results

Summary of Purpose

To assess the efficacy of early thrombolytic therapy with recombinant tissue-type plasminogen activator in the treatment of acute ischemic stroke and to assess the feasibility of conducting a larger, multi-center trial.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 December 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, stratified, double-blind, placebo-controlled trial of 27 patients. Stratification was by whether treatment was begun within 90 minutes or 91 to 180 minutes from onset.

Contacts

Not available